Blogs
We have built the ParagonRx blog in an effort to keep you up to date with what is happening in the world of pharmaceutical risk management, REMS, and optimal product use.
Latest Posts:
- FDLI Conference on REMS: Benefits and Risks Meet Liabilities and Opportunities
- Guest blog by Roger Morris, The LondonBritian Company - You’ve heard all the analogies: Is the glass half empty or half full? Does the dark storm cloud have a silver lining? I was constantly reminded of this during the Food & Drug Law Institute’s latest conference on REMS held February 16 in Washington, D.C., as the [...] - VIOXX - What Could Have Been in the Age of REMS
- Guest blog by Wendy Kaplan Nickel - Perhaps one of the greatest downfalls in drug history was the steep tumble of VIOXX after it was voluntarily pulled from the market in 2004. VIOXX was approved by the FDA in 1999 and quickly became “the” drug for arthritis. It gained widespread acceptance among physicians and over [...]
Previous page: Experience Next page: Webinars